FEMALE BREAST CANCER 2009-2013 JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

Slides:

Advertisements

Similar presentations

BREAST CANCER IN IDAHO This PowerPoint presentation was created as a collaborative effort among the Cancer Data Registry of Idaho/ Idaho.

Advertisements

Sylvia Le April 29, Disparities in Health Care Disparities in health care have serious impact on the quality of health care. Identifying health.

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

SEER PATTERNS OF CARE Kimberly Kimbler, MS, CCRP, CTR Kentucky Cancer Registry

How are cancer statistics kept up to date?.  Example:  Dx stage II colon cancer  Cancer has metastasized to the liver – 2009  How does the.

BREAST CANCER EPIDEMIOLOGY AND BREAST PHYSIOLOGY Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.

Impact of Cancer Diagnosis and Chemotherapy on Mammography Use Xinhua Yu, M.B., Ph.D. A. Marshall McBean, M.D., M.Sc. Beth A. Virnig, Ph.D., M.P.H Division.

By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.

Breast Cancer By: Vincent Russo And Scott Jeffery.

Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.

Breast Cancer By George Rezk.

Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.

The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,

Variations in Cancer Surgery Across the East Midlands and North Trent EMPHIN Forum (Apr 2010) Carolynn Gildea Trent Cancer Registry.

Ethnic Disparities in Early Breast Cancer Management among Asian Americans and Pacific Islanders Rebecca P. Gelber, MD, MPH Department of Medicine, University.

The Relationship of Surgeon and Hospital Volume with Long-Term Survival For Women with Breast Cancer Patrick J. Roohan New York State Department of Health.

Casefinding & Follow-Up Dolores E. McCord, RHIT, CTR Piedmont Hospital Atlanta, Georgia.

Lung Cancer Emily Cauchon Katie Reeves Emily Cauchon Katie Reeves.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

Who, What, and Why of Reports By Kathy Dunaway, CTR.

A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.

SEER Provided Data Mohammad Afnan Baqai 12/3/2009.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.

Differential Diagnoses September 25, You are a psychologist who has been referred 5 cases from the local school district. You have been asked to.

2015 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

Treatment Patterns in the Management of Prostate Cancer: Lessons Learned from the Florida Cancer Data System Vonetta L. Williams, PhD, MPH, CTR June 23,

GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.

The Burden of Cancer in Connecticut Lou Gonsalves Connecticut Tumor Registry

Breast Cancer By Taylor Miller. Who should care? Why? Who? Every woman Why? The facts and statistics.

Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH.

NCDB Report on Breast Cancer at Sibley Cancer Committee Feb Cancer Liaison Physician Karen Lisa Smith MD MPH.

HEAD/NECK CARCINOMA Johns Hopkins Hospital.

Cancer Jeremy Doowage Science Honours Presentation.

Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.

Cancer in Ontario: Overview A Statistical Report.

Developed from information included in the AIHW report Cancer in Australia: in brief 2014 Highlights.

Presented at the NAACCR Annual Conference Quebec City June 22, 2010.

Johns Hopkins Hospital Cancer Registry Melanoma

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

Virginia Cancer Registrars Association and Virginia Cancer Registry Annual Meeting October 3, 2007.

The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator

Lung Cancer Angel.

What does the data tell us? Colorectal CANCER IN NEVADA

NON-SMALL CELL LUNG CANCER

Prognostic significance of tumor subtypes in male breast cancer:

JOHNS HOPKINS HOSPITAL CANCER REGISTRY

Presented By Deborah Schrag at 2016 ASCO Annual Meeting

Johns Hopkins Hospital Malignant and Benign Brain/CNS

JOHNS HOPKINS CANCER REGISTRY 2009

ANALYTIC PANCREATIC CANCER by CLASS N = 369

Johns Hopkins Hospital Cancer Registry

Oncology for Family Medicine Residents:

Shared Positive Affect Shared Negative Affect

Marcelo Calil Instituto Brasileiro de Controle do Câncer

سرطان الثدي Breast Cancer

تهیه کننده: استاد مربوطه: بهار 1392

Estimated current cancer incidence

4155 primary hepatocellular carcinoma with known diagnosis month/year

Arti Parikh-Patel, PhD MPH Cyllene Morris, DVM MPVM

Shared Positive Affect Shared Negative Affect

Presentation transcript:

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014

HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800 FEMALE BREAST CANCER ALL CASES = 3316 ANALYTIC vs. NON-ANALYTIC

HEAD/NECK OF THE SKIN AGE AT DIAGNOSIS, ALL CASES N = 1800 FEMALE BREAST CANCER ALL CASES = 3316 AGE AT DIAGNOSIS

FEMALE BREAST CANCER ALL CASES = 3316 RACE/ETHNICITY

FEMALE BREAST CANCER ALL CASES = 3316 STATE OF RESIDENCE AT DIAGNOSIS

FEMALE BREAST CANCER ALL MARYLAND CASES = 2294 COUNTY OF RESIDENCE AT DIAGNOSIS

FEMALE BREAST CANCER ANALYTIC CASES = 2828* AJCC STAGE *Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere

FEMALE BREAST CANCER ANALYTIC CASES TREATMENT BY STAGE AJCC 0 (555)AJCC I (1095)AJCC II (732)AJCC III (301)AJCC IV (139) Surgery Only Radiation Only Chemotherapy Only Hormone Only Surgery & Radiation Surgery & Chemotherapy Surgery & Hormone Surgery, Radiation & Hormone Surgery, Radiation & Chemotherapy Surgery, Chemotherapy, & Hormone Surgery, Radiation, Chemotherapy, & Hormone Other Combinations ** Not Treated % *Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere **Other treatment combinations include: Radiation/Chemotherapy/Hormone; Chemotherapy/Hormone/Immunotherapy; Radiation/Chemotherapy; Radiation/Hormone; Chemotherapy/Hormone

FEMALE BREAST CANCER 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT

FEMALE BREAST CANCER 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT

FEMALE BREAST CANCER 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT

FEMALE BREAST CANCER 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT